Insilico Medicine, a global leader in artificial intelligence for drug discovery, announced the publication of a paper titled, "Deep learning enables rapid identification of potent DDR1 kinase inhibitors," in Nature Biotechnology.
Artificial Intelligence has the potential to add £630 billion to the UK economy by 2035, concludes an independent review commissioned by the government as part of its Industrial Strategy.